Cargando…

Type IIs restriction based combinatory modulation technique for metabolic pathway optimization

BACKGROUND: One of the most important research subjects of metabolic engineering is pursuing a balanced metabolic pathway, which is the basis of an efficient cell factory. In this work, we dedicated to develop a simple and efficient technique to modulate expression of multiple genes simultaneously,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Lijun, He, Ping, Li, Qingyan, Zhang, Xueli, Bi, Changhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353881/
https://www.ncbi.nlm.nih.gov/pubmed/28302121
http://dx.doi.org/10.1186/s12934-017-0659-z
_version_ 1782515221662793728
author Ye, Lijun
He, Ping
Li, Qingyan
Zhang, Xueli
Bi, Changhao
author_facet Ye, Lijun
He, Ping
Li, Qingyan
Zhang, Xueli
Bi, Changhao
author_sort Ye, Lijun
collection PubMed
description BACKGROUND: One of the most important research subjects of metabolic engineering is pursuing a balanced metabolic pathway, which is the basis of an efficient cell factory. In this work, we dedicated to develop a simple and efficient technique to modulate expression of multiple genes simultaneously, and select for the optimal regulation pattern. RESULTS: A Type IIs restriction based combinatory modulation (TRCM) technique was designed and established in the research. With this technique, a plasmid library containing variably regulated mvaE, mvaS, mvaK (1), mvaD and mvaK (2) of the mevalonate (MVA) pathway were obtained and transformed into E. coli DXS37-IDI46 to obtain a β-carotene producer library. The ratio of successfully assembled plasmids was determined to be 35%, which was increased to 100% when color based pre-screening was applied. Representative strains were sequenced to contain diverse RBSs as designed to regulate expression of MVA pathway genes. A relatively balanced MVA pathway was achieved in E. coli cell factory to increase the β-carotene yield by two fold. Furthermore, the approximate regulation pattern of this optimal MVA pathway was illustrated. CONCLUSIONS: A TRCM technique for metabolic pathway optimization was designed and established in this research, which can be applied to various applications in terms of metabolic pathway regulation and optimization. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-017-0659-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5353881
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53538812017-03-22 Type IIs restriction based combinatory modulation technique for metabolic pathway optimization Ye, Lijun He, Ping Li, Qingyan Zhang, Xueli Bi, Changhao Microb Cell Fact Research BACKGROUND: One of the most important research subjects of metabolic engineering is pursuing a balanced metabolic pathway, which is the basis of an efficient cell factory. In this work, we dedicated to develop a simple and efficient technique to modulate expression of multiple genes simultaneously, and select for the optimal regulation pattern. RESULTS: A Type IIs restriction based combinatory modulation (TRCM) technique was designed and established in the research. With this technique, a plasmid library containing variably regulated mvaE, mvaS, mvaK (1), mvaD and mvaK (2) of the mevalonate (MVA) pathway were obtained and transformed into E. coli DXS37-IDI46 to obtain a β-carotene producer library. The ratio of successfully assembled plasmids was determined to be 35%, which was increased to 100% when color based pre-screening was applied. Representative strains were sequenced to contain diverse RBSs as designed to regulate expression of MVA pathway genes. A relatively balanced MVA pathway was achieved in E. coli cell factory to increase the β-carotene yield by two fold. Furthermore, the approximate regulation pattern of this optimal MVA pathway was illustrated. CONCLUSIONS: A TRCM technique for metabolic pathway optimization was designed and established in this research, which can be applied to various applications in terms of metabolic pathway regulation and optimization. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-017-0659-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-16 /pmc/articles/PMC5353881/ /pubmed/28302121 http://dx.doi.org/10.1186/s12934-017-0659-z Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ye, Lijun
He, Ping
Li, Qingyan
Zhang, Xueli
Bi, Changhao
Type IIs restriction based combinatory modulation technique for metabolic pathway optimization
title Type IIs restriction based combinatory modulation technique for metabolic pathway optimization
title_full Type IIs restriction based combinatory modulation technique for metabolic pathway optimization
title_fullStr Type IIs restriction based combinatory modulation technique for metabolic pathway optimization
title_full_unstemmed Type IIs restriction based combinatory modulation technique for metabolic pathway optimization
title_short Type IIs restriction based combinatory modulation technique for metabolic pathway optimization
title_sort type iis restriction based combinatory modulation technique for metabolic pathway optimization
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353881/
https://www.ncbi.nlm.nih.gov/pubmed/28302121
http://dx.doi.org/10.1186/s12934-017-0659-z
work_keys_str_mv AT yelijun typeiisrestrictionbasedcombinatorymodulationtechniqueformetabolicpathwayoptimization
AT heping typeiisrestrictionbasedcombinatorymodulationtechniqueformetabolicpathwayoptimization
AT liqingyan typeiisrestrictionbasedcombinatorymodulationtechniqueformetabolicpathwayoptimization
AT zhangxueli typeiisrestrictionbasedcombinatorymodulationtechniqueformetabolicpathwayoptimization
AT bichanghao typeiisrestrictionbasedcombinatorymodulationtechniqueformetabolicpathwayoptimization